5 Fights Over $25B Actavis-Forest Deal Merge In NY
By Stewart Bishop ( April 28, 2014, 4:17 PM EDT) -- A New York judge on Monday consolidated five shareholder class actions pending in the state that are seeking to block generic-drug maker Actavis PLC's proposed $25 billion acquisition of Carl Icahn-backed Forest Laboratories Inc....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.